Personalized Treatment Plans
495 articles
Research
July 26, 2016 • 2 Min
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Disease Management
May 4, 2020 • 5 Min
Where Caregivers Can Turn When they Need Support
Social worker Lauren Shaffer provides information about how and where caregivers for pancreatic cancer patients can get support and help for themselves.
Research
June 27, 2017 • 2 Min
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
Research
June 15, 2017 • 2 Min
Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.